Preceptis Medical, Inc. — SEC Form D Filing
Preceptis Medical, Inc. filed an SEC Form D on May 1, 2026, reporting $2.56M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- May 1, 2026
- Amount reported
- $2.56M
- Round stage
- Seed
- Industry
- Health Care
- Website
- https://www.hummingbirdeartubes.com/company/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Pediatric ear tube placement is the most common pediatric procedure and exposes children under 3 to the risks of general anesthesia and associated parental stress.
Solution
Preceptis Medical developed the FDA-cleared Hummingbird® Tympanostomy Tube System (TTS), a minimally invasive, office-based device that places ear tubes without general anesthesia, reducing costs and allowing quick recovery.
Verdict
Investors said yes primarily because the Hummingbird system presents a significant advancement in a routine pediatric procedure, minimizing anesthesia risks and streamlining operations for ENT specialists. They were implicitly betting on a growing willingness among parents and doctors to embrace less invasive solutions, not because there was a well-defined market or a strong competitive edge. However, the limited upside lies in the niche nature of pediatric ENT interventions, which could limit scalability compared to broader health care solutions.
Source: SEC EDGAR Form D filing